| Hodgkin Lymphoma studied in …STUDIED_INderived200 of 972show all (up to 200) |
|---|
| → studied in | NCT01087294Phase 1 · completed Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01676805recruiting Tissue Collection for Studies of Lymph Cancer · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02682667recruiting Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03418038Phase 2 · recruiting Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03560752Phase 1 · active not recruiting CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02940301Phase 2 · active not recruiting Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03618550Phase 2 · recruiting Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981899Phase 1/Phase 2 · active not recruiting A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06398457early Phase 1 · recruiting Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838649Phase 1 · not yet recruiting Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07790913Phase 2 · not yet recruiting Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039676active not recruiting Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00339963completed Genome Expression in Lymphoma, Leukemia and Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04561206Phase 2 · recruiting Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04935684Phase 2 · recruiting Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05615636Phase 2 · recruiting A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01947140Phase 1/Phase 2 · terminated Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04938232Phase 2 · active not recruiting Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233347Phase 2 · active not recruiting Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03407144Phase 2 · active not recruiting Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667) · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03849651Phase 2 · active not recruiting TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05798897Phase 1 · recruiting Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06002828active not recruiting Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06137144Phase 1/Phase 2 · recruiting AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies. · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03517137Phase 2 · active not recruiting Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05300282Phase 1/Phase 2 · active not recruiting Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05934084NA · recruiting Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05272384Phase 1 · recruiting Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05589896Phase 1/Phase 2 · active not recruiting A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06680661Phase 2 · suspended ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07710781NA · not yet recruiting Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05595577NA · active not recruiting Improving Exercise Capacity With a Tailored Physical Activity Intervention · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06745076Phase 2 · recruiting Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05039073Phase 2 · recruiting Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07444632Phase 1 · recruiting Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03179917Phase 2 · active not recruiting Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01333046Phase 1 · completed Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05508867Phase 2 · completed A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008) · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06421987recruiting Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05886036Phase 2 · recruiting Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07551583Phase 2 · recruiting Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793006NA · recruiting New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06383338Phase 1 · recruiting A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma. · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07256158Phase 3 · recruiting PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04288726Phase 1 · active not recruiting Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05857969Phase 1 · recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Childhood Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03016871Phase 2 · active not recruiting Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05705531recruiting A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03150329Phase 1 · active not recruiting Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL. · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07514819NA · recruiting Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05922904Phase 2 · active not recruiting PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07021989Phase 2 · recruiting ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07275216Phase 2 · recruiting Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01896999Phase 1/Phase 2 · active not recruiting Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05977673Phase 2 · recruiting Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03843294Phase 1 · active not recruiting Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04537871active not recruiting Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02227199Phase 1/Phase 2 · completed Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07451054Phase 1 · recruiting CD45BE-HSPC + CART-45 Cells · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092451Phase 1/Phase 2 · recruiting Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02861417Phase 2 · active not recruiting Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06090864Phase 1/Phase 2 · recruiting ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907488Phase 3 · active not recruiting Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07259304active not recruiting Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03259503Phase 1 · completed Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02166463Phase 3 · active not recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Childhood Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02506933Phase 2 · active not recruiting Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03598608Phase 1/Phase 2 · terminated Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05362773Phase 1 · active not recruiting A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06150664Phase 1 · recruiting A Phase 1 of CTX-8371 in Patients With Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07020533Phase 1 · recruiting A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07729397Phase 1 · not yet recruiting Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30) · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05346809Phase 2 · active not recruiting Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05714553Phase 1/Phase 2 · terminated NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07720011Phase 2 · completed Interim PET/CT-adapted Use of PD-1 Inhibitor Combined With De-escalated Chemotherapy-AVD in Classic Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03739502Phase 2 · active not recruiting A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06176690Phase 1 · recruiting Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00923442enrolling by invitation Biology Studies of Hematologic Cancers · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07164469Phase 2 · not yet recruiting Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05400122Phase 1 · suspended Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06580002Phase 2 · recruiting Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06164275Phase 2 · active not recruiting Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04685616Phase 3 · recruiting Brentuximab Vedotin in Early Stage Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04799275Phase 2/Phase 3 · active not recruiting Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07572123Phase 2/Phase 3 · not yet recruiting Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01351545recruiting A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02332668Phase 1/Phase 2 · recruiting A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06120504Phase 1 · terminated A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06254495Phase 1 · terminated A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06377540Phase 2 · recruiting MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04788043Phase 2 · terminated Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04292626Phase 1 · completed Molecular Imaging of Lymphoma Using Labeled Technetium-99m 1-Thio-D-Glucose · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05255601Phase 1/Phase 2 · terminated A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04664179Phase 1 · recruiting EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | EBV-Related Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01657331Phase 1/Phase 2 · completed Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03697408Phase 1/Phase 2 · active not recruiting Itacitinib + Everolimus in Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04510636Phase 2 · recruiting Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07652476not yet recruiting Neurocognitive Assessment in Long-Term Survivors of Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00840047Phase 2 · active not recruiting Methionine PET/CT Studies In Patients With Cancer · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02256137active not recruiting A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03050268recruiting Familial Investigations of Childhood Cancer Predisposition · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03361020active not recruiting Obstructive Sleep Apnea in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03755804Phase 2 · active not recruiting Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03681561Phase 1/Phase 2 · recruiting Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03622788Phase 1/Phase 2 · active not recruiting Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07641010Phase 1/Phase 2 · not yet recruiting PD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02917083Phase 1 · recruiting CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30) · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222345NA · recruiting Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02663297Phase 1 · active not recruiting Administration of T Lymphocytes for Prevention of Relapse of Lymphomas · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107198Phase 2 · completed Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05723055Phase 2 · active not recruiting Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01868451NA · completed Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05800210Phase 2 · recruiting Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06131801recruiting Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05162976Phase 1 · active not recruiting CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07623850Phase 1 · recruiting A Phase I Study of JLM019 Injection · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04758650Phase 2 · terminated Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195633Phase 2 · recruiting Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06822855recruiting Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04640779Phase 1 · completed Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05100056recruiting A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00846742Phase 2 · active not recruiting Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03434730Phase 2 · completed Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01476410Phase 2 · completed Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Adult Mixed Cellularity Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06812858Phase 2 · recruiting PD-1 Inhibitors Maintenance for cHL Post-autoHCT · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06098430recruiting Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07575893Phase 1 · not yet recruiting CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01790152recruiting Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02362997Phase 2 · completed Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02797470Phase 1/Phase 2 · active not recruiting Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05355051Phase 2 · recruiting A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03246906Phase 2 · terminated Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05404945Phase 2 · active not recruiting Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07566377Phase 2 · recruiting Cord Blood Transplantation in Children and Young Adults With Blood Cancer · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02362035Phase 1/Phase 2 · completed ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01703949Phase 2 · active not recruiting Brentuximab Vedotin With or Without Nivolumab in Treating Patients With Relapsed or Refractory CD30+ Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06870487Phase 1 · terminated A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01920932Phase 2 · active not recruiting Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Childhood Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07555210NA · recruiting Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03580564Phase 2 · completed An Open, Multicenter Phase II Study to Evaluate the Safety and Efficacy of KL-A167 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04888741Phase 2 · recruiting Methods of T Cell Depletion Trial (MoTD) · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04636255NA · completed Physical Capacity in Hodgkin Lymphoma Survivors · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05337735Phase 2 · suspended A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03057795Phase 2 · active not recruiting Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05949931Phase 2 · recruiting Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231412Phase 3 · completed Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00131014recruiting Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05550948NA · active not recruiting Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06377566Phase 2 · recruiting A Study of BV-AVD in People With Bulky Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04134325early Phase 1 · active not recruiting Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05605119Phase 1 · terminated First in Human, Dose Escalation, Dose Expansion Study of AUR105 · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03935282NA · completed Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491370Phase 1/Phase 2 · recruiting Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06617286Phase 1/Phase 2 · not yet recruiting CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03192397Phase 1/Phase 2 · active not recruiting Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01890486recruiting The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213665Phase 2 · completed Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05481437recruiting A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06487624Phase 1 · recruiting An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06923397NA · recruiting Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03236935Phase 1 · completed Phase Ib of L-NMMA and Pembrolizumab · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05972577NA · completed Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544968Phase 1 · recruiting Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07234487Phase 2 · recruiting Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02684708Phase 3 · completed Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915246Phase 2 · recruiting A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02287311Phase 1 · active not recruiting Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01315132Phase 2 · completed A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04726501Phase 4 · active not recruiting CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06563245Phase 2/Phase 3 · recruiting Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02213913Phase 1/Phase 2 · completed Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06059391Phase 2 · recruiting CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01758042NA · completed Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05502250Phase 2 · active not recruiting Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05540340Phase 1 · active not recruiting A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03652441Phase 2 · completed Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01788839recruiting Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01555892Phase 1 · recruiting Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04486391Phase 3 · terminated Tislelizumab Monotherapy Versus Salvage Chemotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01712490Phase 3 · completed A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05938127NA · terminated Impact of Respiratory Training in Lymphoma Survivors · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06831370Phase 4 · recruiting A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02684292Phase 3 · completed Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204) · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03033914Phase 1/Phase 2 · active not recruiting A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL) · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06484920Phase 2 · recruiting A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01358747Phase 3 · completed Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01192464Phase 1 · active not recruiting EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04067037Phase 2 · active not recruiting Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05180097Phase 2 · recruiting Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05839210NA · recruiting Lifestyle Intervention of Food and Exercise for Lymphoma Survivors · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04681105Phase 1 · completed Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07374068active not recruiting Prognostic Model of Elderly Hodgkin Lymphoma in China · condition mapped ONTOLOGY_EXACT · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02408861Phase 1 · terminated Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07356882recruiting European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin Lymphoma · condition mapped CURATED_BROADER · 972 trials mapped (220 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01483664active not recruiting Communication Skills Intervention to Promote Transition Into Survivorship · condition mapped ALIAS · 972 trials mapped (220 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |